Calithera Biosciences Receives $27,150,000 New Funding

  • Feed Type
  • Date
    10/25/2013
  • Company Name
    Calithera Biosciences
  • Mailing Address
    343 Oyster Point Blvd. South San Francisco, CA 94080
  • Company Description
    The primary mission of Calithera Biosciences is to develop novel therapeutic approaches to the treatment of cancer by using small molecules to activate, rather than inhibit, enzymes. Our first program is focused on developing activators of caspases, the proteases that induce apoptosis, for the treatment of cancer.
  • Website
    http://www.calithera.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $27,150,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for any solicitation details, if applicable.
  • M&A Terms
  • Venture Investor
    Undisclosed

By posting a comment, you agree to our terms and conditions.